Context. Little is known about the phenotypic and molecular characteristics associated with various domains of quality of life (QOL) in women after breast cancer surgery.
Introduction
Although a number of reviews noted that some women report poorer quality of life (QOL) after breast cancer surgery, findings across studies are inconsistent. 1e3 A number of explanations exist for these inconsistent findings. First, although researchers accept that a comprehensive evaluation of QOL should include the assessment of multiple domains, 4 the QOL instruments used across studies are extremely variable. 5 Second, the timing of the QOL assessments was not consistent which makes it difficult to determine the impact of specific treatments on breast cancer patients' QOL. Third, most longitudinal studies of QOL in breast cancer patients reported mean scores, which do not allow for an evaluation of interindividual variability in the various domains of QOL.
Despite the fact that numerous studies have evaluated QOL in patients with breast cancer, 1e3 little information is available on phenotypic characteristics that predict QOL outcomes in the first six months after breast cancer surgery. In the only two studies identified, 6,7 poorer overall QOL scores for up to two years after breast cancer surgery were associated with a number of demographic (e.g., not having a partner at the time of surgery 6 ); psychological (e.g., higher levels of mood disturbance, 7 anxiety and depression, 6 poorer body image 7 ); and clinical (e.g., higher number of comorbid conditions, 6 receipt of adjuvant chemotherapy (CTX), 6 higher number of positive lymph nodes 6,7 ) characteristics.
Only one study was found, which evaluated for phenotypic characteristics associated with specific domains of QOL. 8 In this study that evaluated patients before and at three and twelve months after breast cancer surgery, older age was associated with improved social and psychological well-being but with poorer physical well-being. In addition, higher education was associated with higher psychological well-being. Given that QOL is such an important patient-reported outcome, 9 additional research is needed to determine which phenotypic characteristics are associated with poorer outcomes across multiple domains of QOL.
Recent evidence suggests that 11%e35% of QOL is heritable. 10 As noted in one review, 11 polymorphisms in inflammatory, dopaminergic, serotonergic, neurotrophin signaling, and neuroactive ligand-receptor interaction pathways were associated with changes in QOL. Although some pathways were associated with specific QOL domains (e.g., dopaminergic pathway genes and emotional functioning), others (e.g., inflammation) were linked to changes in multiple domains of QOL. Although the exact mechanisms by which polymorphisms in inflammatory genes contribute to interindividual variability in QOL are unknown, inflammation may influence the severity of symptoms experienced by cancer patients, which in turn impacts functional status and QOL. 12 Although no studies evaluated for associations between QOL and genetic variants in breast cancer patients, five studies have reported on associations between a number of polymorphisms in inflammatory pathways (i.e., cytokines) and QOL in cancer patients. 13e17 In a study of lung cancer survivors, 14 variations in a number of cytokine genes were associated with changes in physical functioning (i.e., interleukin [IL] 1B, IL10, IL1 receptor antagonist [IL1RN]), mental health (IL1RN ), emotional role functioning (IL6), and social functioning (IL6, IL1RN, tumor necrosis factor super family [TNFSF] ). In a separate study of the same cohort, 15 three single-nucleotide polymorphisms (SNPs: rs3858300, rs10741191, and rs10741191) in the O-6-methylguanine-deoxyribonucleic acid (DNA) methyltransferase gene were associated with 34%, 36%, and 30% increased risk of lower QOL scores, respectively.
In separate analyses of the same cohort, 13 carrying one or two doses of the rare ''G'' alleles for prostaglandinendoperoxide synthase 2 (PTGS2) rs5277 and rs5275 were associated with lower social function and mental health scores, respectively.
In our previous studies, 16,17 subgroups of oncology patients and their family caregivers (FCs) with distinct QOL trajectories were identified. In terms of social well-being, 17 individuals who were heterozygous or homozygous for the rare ''G'' allele for nuclear factor kappa beta 2 (NFKB2) rs7897947 had a 54% decrease in the odds of belonging in the lower social well-being class. In terms of overall QOL, 16 individuals who were heterozygous or homozygous for the rare ''C'' allele for IL1R2 rs4141134 had a 64% decrease in the odds of belonging to the lower total QOL class. In contrast, individuals who were homozygous for the rare ''G'' allele for NFKB2 rs12772374 were 47.7 times more likely to belong to the lower total QOL class. All five studies provide preliminary evidence of associations between genetic polymorphisms and QOL outcomes. 13e17 However, additional studies of oncology patients are needed to confirm these associations Therefore, the purposes of this study, in a sample of women with breast cancer (n ¼ 398), were as follows: to identify latent classes with distinct trajectories of QOL from before surgery through six months after surgery and to evaluate for differences in demographic and clinical characteristics, as well as for polymorphisms in cytokine genes, between these latent classes.
Materials and Methods

Patients and Settings
This analysis is part of a larger, longitudinal study whose methods are described in detail elsewhere. 18e21 Women were eligible to participate if they were $18 years; were scheduled to undergo unilateral breast cancer surgery; were able to read, write, and understand English; and gave written informed consent. Patients were excluded if they were having bilateral breast cancer surgery or had distant metastasis at the time of diagnosis.
Instruments
Patients completed a demographic questionnaire, the Karnofsky Performance Status (KPS) scale, 22 and the Self-administered Comorbidity Questionnaire. 23 QOL was evaluated using the Quality of Life-ScaleePatient Version (QOL-PV). 24, 25 The QOL-PV consists of 41 items that measure four domains of QOL in cancer patients (i.e., physical well-being, psychological wellbeing, social well-being, spiritual well-being). Items are rated on a 0e10 numeric rating scale. Patients were asked to rate each item based on their life ''at this time.'' Mean subscale and total scores were calculated. Higher scores indicate better QOL. The QOL-PV has well-established validity and reliability. 24, 25 Cronbach's alphas for the QOL-PV physical well-being, psychological well-being, social well-being, and spiritual wellbeing, as well as the total QOL score, were as follows: 0.80, 0.86, 0.80, 0.63, and 0.86, respectively.
Study Procedures
The study was approved by the Committee on Human Research at the University of California, San Francisco and by the Institutional Review Board at each of the study sites. During the preoperative visit, a clinician explained the study; determined the patient's willingness to participate; and introduced her to the research nurse. The research nurse met with the woman, determined eligibility, and obtained written informed consent before surgery. After obtaining consent, patients completed the enrollment questionnaires at an average of four days before surgery. Patients completed the QOL-PV at enrollment and monthly for six months (i.e., seven assessments). Medical records were reviewed for disease and treatment information.
Genomic Analyses Gene Selection. The proinflammatory genes evaluated in this study were as follows: chemokine (C-C-C motif) ligand 8 (CXCL8, previous gene symbol IL8), interferon gamma (IFNG), IFNGR1, IL1R1, IL2, IL17A, and members of the TNF family (i.e., lymphotoxin alpha [LTA], TNF ). The anti-inflammatory genes were as follows: IL1R2, IL4, IL10, and IL13. In addition, IFNG1, IL1B, and IL6 possess pro-and antiinflammatory functions and NFKB1 and NFKB2 that regulate transcription of cytokine genes were evaluated. 26 All genes were named using the Human Genome Organization Gene Nomenclature Committee database (http://www.genenames.org).
Blood Collection and Genotyping. Of the 398 patients who completed the enrollment assessment, 310 provided a blood sample from which DNA was isolated from peripheral blood mononuclear cells. Genomic DNA was extracted from peripheral blood mononuclear cells using the PUREGene DNA Isolation System (Invitrogen, Carlsbad, CA), quantitated using Nanodrop Spectrophotometer (ND-1000) and normalized to a concentration of 50 ng/mL. Samples were genotyped using a custom array on the Golden Gate genotyping platform (Illumina, San Diego, CA) and processed according to the standard protocol using GenomeStudio (Illumina, San Diego, CA). SNP Selection. SNPs were required to be common (i.e., a minor allele frequency $0.05) in public databases. SNPs with call rates of <95% or Hardy-Weinberg P-values of <0.001 were excluded. As shown in Supplementary Table, 81 SNPs from a total of 104 SNPs among 15 candidate genes passed all the quality control filters and were included in the genetic association analyses. Potential regulatory involvement of the significant SNPs identified in this analysis was investigated using SNPinfo (FuncPred, http://www.niehs. nih.gov/snpinfo). 27
Statistical Analyses for the Phenotypic Data
Data were analyzed using SPSS version 23 28 and STA-TA version 13. 29 Descriptive statistics and frequency distributions were generated for sample characteristics. Parametric and nonparametric tests were used to evaluate for differences in demographic and clinical characteristics among the latent classes. A P-value of <0.05 was considered statistically significant.
Unconditional growth mixture modeling (GMM) with robust maximum likelihood estimation was carried out to identify latent classes with distinct QOL trajectories using Mplus version 5.21 (Muthen and Muthen, Los Angeles, CA). These methods are described in detail elsewhere. 21 In brief, a single growth curve that represented the ''average'' change trajectory was estimated for the entire sample. Then, the number of latent growth classes that best fit the data was identified using guidelines recommended in the literature. 30e32
Statistical Analyses for the Genetic Data
Allele and genotype frequencies were determined by gene counting. Hardy-Weinberg equilibrium was assessed by chi-squared or Fisher exact tests. Measures of linkage disequilibrium (LD; i.e., D 0 and r 2 ) were computed from the patients' genotypes with Haploview 4.2. The LD-based haplotype block definition was based on D 0 confidence interval. 33 Haplotypes were constructed using the program PHASE version 2.1. 34 Only inferred haplotypes that occurred with a frequency of $15% were included in the association analyses.
Ancestry informative markers were used to minimize confounding due to population stratification. 35e37 Homogeneity in ancestry among patients was verified by principal component analysis, 38 using HelixTree (GoldenHelix, Bozeman, MT). The first three PCs were selected to adjust for potential confounding due to population substructure (i.e., race/ethnicity) by including them in all the logistic regression models. One hundred six ancestry informative markers were included in the analysis.
For association tests, three genetic models were assessed for each SNP: additive, dominant, and recessive. The genetic model that best fit the data (i.e., most significant P-value) was selected for each SNP. Logistic regression analyses, that controlled for significant covariates, as well as genomic estimates of and self-reported race/ethnicity, were used to evaluate the associations between genotype and QOL class membership. Only those genetic associations identified as significant from the bivariate analyses were evaluated in the multivariate analyses. A backward stepwise approach was used to create a parsimonious model. Except for genomic estimates of self-reported race/ ethnicity, only predictors with a P-value of <0.05 were retained in the final model. Genetic model fit and both unadjusted and covariate-adjusted odds ratios were estimated using STATA version 13. 29 As was done in our previous studies, 18,20,39e52 based on the recommendations in the literature, 53,54 as well as the implementation of rigorous quality controls for genomic data, the nonindependence of SNPs/haplotypes in LD, and the exploratory nature of the analyses, adjustments were not made for multiple testing. In addition, significant SNPs identified in the bivariate analyses were evaluated further using logistic regression analyses that controlled for differences in phenotypic characteristics, potential confounding due to population stratification, and variations in other SNPs/haplotypes within the same gene. Only those SNPs that remained significant were included in the final presentation of the results. Therefore, the significant independent associations reported are unlikely to be due solely to chance. Unadjusted (bivariate) associations are reported for all the SNPs that passed quality control criteria in Supplementary Table, to allow for subsequent comparisons and meta-analyses.
Results
GMM Analyses
The fit indices used for GMM class selection are listed in Table 1 . The parameter estimates for the identified classes are listed in Table 2 . For physical well-being, three classes were identified ( Fig. 1a ). For psychological well-being, a one-class solution was selected because a model with a larger number of classes was not supported (data not shown; Fig. 1b ). The mean psychological well-being score at enrollment was 5.76 (AE1.82). This score increased slightly over time. For social well-being, two classes were identified ( Fig. 1c ). For spiritual well-being, a one-class solution was selected because a model with a larger number of classes was not supported (data not shown; Fig. 1d ). The mean spiritual well-being score at enrollment was 5.72 (AE1.84). These scores remained relatively stable over time. For the total QOL scores, two classes were identified ( Fig. 1e ).
Physical Well-being
For physical well-being, the largest group of patients was named the higher physical well-being class (n ¼ 207, 52.4%). These patients had a mean score of 8.931 (AE0.729) before surgery, and their scores The three-class model was selected because it had a smaller BIC than the two-class model. Furthermore, although the BIC for the four-class model was smaller, the latent variable covariance matrices for two classes were not positive definite, and one class had only 10 cases (2.7% of the sample), indicating that the estimation for the four-class model was unreliable. g Two-class model was selected, because the BIC was smaller than the one-class solution and the VLMR was significant. Furthermore, although the BIC is smaller for the three-class solution, one class in the three-class solution contained only 26 observations (6.6% of the sample)dtoo small a class size to be reliable. j Two-class model was selected, because it had the smallest BIC and a significant VLMR. Furthermore, the VLMR is not significant for the three-class model.
remained relatively stable over time. The second largest group was named the lower physical wellbeing class (n ¼ 112, 28.4%) who had a mean enrollment score of 6.220 (AE1.588) that remained relatively stable over time. The third group was named the changing physical well-being class (n ¼ 76, 19.2%). These patients had a mean enrollment score of 8.070 (AE1.172). Their mean scores decreased to 5.767 (AE1.266) at three months and then increased to 7.382 (AE1.126) at six months after surgery. Compared with the higher class, patients in the changing and lower physical well-being classes were younger; were more likely to have had an axillary lymph node dissection (ALND) and to have received adjuvant CTX; and were less likely to have gone through menopause (Table 3 ). Compared to the higher and changing classes, patients in the lower physical well-being class had a lower KPS score. Compared to the higher class, patients in the lower physical well-being class had a higher Selfadministered Comorbidity Questionnaire score; a higher body mass index (BMI); were less likely to be white; and were less likely to have received adjuvant radiation therapy (RT). Compared to the Changing class, patients in the lower physical well-being class were more likely to have a lower income, have a higher stage of disease at the time of diagnosis, had received neoadjuvant CTX, and less likely to have received adjuvant CTX. Compared to the higher class, patients in the changing class were less likely to have received RT in the six months after surgery.
Social Well-being
For social well-being, one group of patients was named the higher social well-being class (n ¼ 212, 53.8%), they had a mean enrollment score of 8.099 (AE1.196), and their mean scores were relatively stable over time. The second subgroup was named the lower social well-being class (n ¼ 182, 46.2%). They had a mean enrollment score of 5.604 (AE1.905) and their scores decreased slightly over time.
Compared to the higher social well-being class, patients in the lower class were younger; less likely to be white; had a lower KPS score; and were less likely to have gone through menopause. In addition, patients in the lower social well-being class had a higher stage of disease at diagnosis, more likely to have received neoadjuvant CTX, more likely to have had an ALND, less likely to have received adjuvant RT, and more likely to have received adjuvant CTX.
Total QOL
For total QOL, one class was named the higher total QOL class (n ¼ 169, 42.7%). These patients had a mean enrollment score of 7.054 (AE1.074) and their scores increased slightly over time. A second group was named the lower total QOL class (n ¼ 227, 57.3%). These patients had a mean enrollment score of 5.983 (AE1.318) and their scores decreased slightly over time.
Compared to the higher total QOL class, patients in the lower class were significantly younger, had a lower KPS score, and were less likely to have gone through menopause. In addition, patients in the lower class had a higher stage of disease at diagnosis, were more likely to have had an ALND, were less likely to have received adjuvant CTX, and were more likely to have received adjuvant RT.
Candidate Gene Analyses
Candidate gene analyses are summarized in Supplementary Table. Physical Well-being
In the ordinal logistic regression analyses for physical well-being, after controlling for age, KPS score, BMI, receipt of CTX during the six months after surgery (i.e., adjuvant CTX), as well as self-reported and genomic estimates of race/ethnicity, and other significant variants in the same gene, only the models fit for CXCL8 rs4073, NFKB2 rs11574849, and TNFSF rs1800683 remained significant. Pairwise comparisons revealed that the relationship between subgroup membership and the CXCL8 genotype was due to differences in genotype frequencies between the higher versus changing physical well-being class (P ¼ 0.002, Table 4 , Fig. 2a ). Patients who were homozygous for the rare ''A'' allele had an 80% decrease in the odds of belonging to the changing physical well-being class.
For NFKB2 rs11574849, pairwise comparisons revealed that the relationship between subgroup membership and genotype was due to differences in genotype frequencies between the changing versus the lower physical well-being classes (P ¼ 0.016, Table 4 , Fig. 2b ). Patients who were heterozygous or homozygous for the rare ''A'' allele had a 76% decrease in the odds of belonging to the lower physical well-being class.
For TNFSF rs1800683, pairwise comparisons revealed that the relationship between subgroup membership and genotype was due to differences in the genotype frequencies between the changing versus the lower physical well-being classes (P ¼ 0.013, Table 4 , Fig. 2c ). Patients who were heterozygous or homozygous for the rare ''A'' allele had a 2.73 increased odds of belonging to the lower physical well-being class. 
Body mass index (kg/m 2 ) 25.9 (5.1) 27.1 (6.0) 28.2 (7.6) 
Social Well-being
In the regression analyses, after controlling for age, KPS score, receipt of adjuvant CTX, self-reports and genomic estimates of race/ethnicity, and other significant covariates in the same gene, the models fit for IL1B rs1143623 remained significant. Patients who were heterozygous or homozygous for the rare ''C'' allele had a 1.94 increased odds of belonging to the lower social well-being class (P ¼ 0.018, Table 5 , Fig. 3a ).
Total QOL
In the regression analyses for total QOL, after controlling for age, KPS score, receipt of adjuvant CTX, self-reports and genomic estimates of race/ethnicity, and other significant variations in the same gene, the models fit for IL13 rs1881457 and NFKB1 rs4648068 remained significant. Patients who were heterozygous or homozygous for the rare ''C'' allele for IL13 rs1881457 had a 1.78 increased odds of belonging to the lower total QOL class (P ¼ 0.033, Table 6 , Fig. 3b ). Patients who were homozygous for the rare ''G'' allele for NFKB1 rs4648068 had a 3.12 increased odds of belonging to the lower total QOL class (P ¼ 0.005, Table 6 , Fig. 3c ).
Discussion
This study is the first to use GMM to identify subgroups of women who reported distinct trajectories for physical well-being, social well-being, and overall QOL before and six months after breast cancer surgery. In addition, this study is the first to evaluate for demographic and clinical characteristics, as well as for variations in cytokine genes, that were associated with poorer outcomes across these QOL domains. In terms of physical well-being, three classes (i.e., higher, changing, and lower) were identified. For social well-being and overall QOL, two classes (i.e., higher and lower) were identified. Only one class was identified for the psychological well-being and spiritual well-being. In the only study that used GMM to evaluate for distinct QOL trajectories in breast cancer patients who were followed for four years after surgery, 55 four latent classes were identified for both the Physical and Mental component summary scores (i.e., PCS and MCS, respectively) of the SF-36. One consistent finding across both studies was the identification of a group of women with consistently higher physical well-being scores that included approximately 50% of both samples.
Although the samples in our study and the previous study 55 were relatively similar, the inconsistent findings related to psychological well-being may be partially explained by differences in the follow-up period. In addition, we used a disease-specific measure of QOL, whereas the previous study used a generic measure of QOL. Replication of these findings, using both generic and disease-specific measures, is warranted to explore this hypothesis.
Of note, we previously reported four subgroups of patients with different depressive symptom trajectories 21 and two subgroups of patients with different anxiety symptom trajectories 56 in the same cohort of patients. The reason that we did not identify subgroups of patients with distinct trajectories of For each model, the first three principal components identified from the analysis of ancestry informative markers as well as self-reported race/ethnicity (i.e., white, black, Asian/Pacific Islander, Hispanic/mixed ethnic background/other) were retained in all models to adjust for potential confounding due to race or ethnicity (data not shown). Predictors evaluated in each model included genotype (CXCL8 rs4073: TT þ TA vs. AA; NFKB2 rs11574849: GG vs. GA þ AA; TNFSF rs1800683: GG vs. GA þ AA), age, KPS score, BMI, and whether the patient received CTX during the first six months after surgery (i.e., adjuvant CTX).
psychological well-being may be because this subscale of the QOL-PV evaluates other dimensions of psychological well-being (e.g., sense of control, fear of recurrence) that may be of equal concern to all women immediately after breast cancer surgery.
No studies have used the QOL-PV to evaluate QOL in breast cancer patients before and after surgery. Most of the previous QOL-PV studies evaluated longterm survivors of breast cancer (i.e., at least five years after treatment). 57e60 Across all the subscale and total QOL scores in our study, our scores for the various latent classes were in the range of these previous reports. These findings suggest that across the trajectory of treatment for breast cancer and well into survivorship, a considerable amount of interindividual variability exists across the various QOL domains. The use of latent class analyses in future studies may help to identify higher risk groups. Fig. 2 . a) Differences among the physical well-being (PWB) latent classes in the percentages of patients who were homozygous or heterozygous for the common allele (TT þ TA) or homozygous for the rare allele (AA) for rs4073 in chemokine (C-C-C motif) ligand 8 (CXCL8). Values are plotted as unadjusted proportions with corresponding P-value. b) Differences among the PWB latent classes in the percentages of patients who were homozygous for the common allele (GG) or heterozygous or homozygous for the rare allele (GA þ AA) for rs11574849 in nuclear factor kappa beta 2 (NFKB2). Values are plotted as unadjusted proportions with corresponding P-value. c) Differences among the PWB latent classes in the percentages of patients who were homozygous for the common allele (GG) or heterozygous or homozygous for the rare allele (GA þ AA) for rs1800683 in tumor necrosis factor super family (TNFSF ). Values are plotted as unadjusted proportions with corresponding P-value. For each model, the first three principal components identified from the analysis of ancestry informative markers as well as self-reported race/ethnicity (i.e., white, black, Asian/Pacific Islander, Hispanic/mixed ethnic background/other) were retained in all models to adjust for potential confounding due to race or ethnicity (data not shown). Predictors evaluated in each model included genotype (IL1B rs1143623: GG vs. GC þ CC), age (in 10year increments), KPS score (in 10-point increments), and whether the patient received CTX during the first six months after surgery (i.e., adjuvant CTX).
In our previous studies that used GMM to evaluate various domains and overall QOL of patients undergoing radiation therapy and their FCs, 16,17 we identified two latent classes (i.e., higher and lower) for physical well-being, psychological well-being, social well-being, and total QOL scores. The mean scores at enrollment and the trajectories for the higher physical well-being class, social well-being, and total QOL classes were similar across our two studies. For example, the mean enrollment score (8.919) and trajectory of the higher physical well-being class in the previous study 17 were similar to those of the present study. In addition, for both studies, only one class was identified for the spiritual well-being domain, and the trajectory remained relatively stable over time. These consistent findings suggest that interindividual variability in various domains of QOL may be related to factors other than the diagnosis of cancer and the effects of treatment.
Demographic and Clinical Characteristics Associated With Latent Class Memberships
Younger age, poorer functional status, and receipt of adjuvant CTX were the three phenotypic characteristics that remained significant in all the multivariable models. Consistent with previous reports, 61,62 younger women were more likely to be in the worse QOL classes. Perhaps, younger cancer patients have more responsibilities 63 and/or experience a higher symptom burden during treatment. 64 However, in two studies of women after breast cancer surgery with a similar age profile, 8,55 older age was associated with lower physical well-being scores. This inconsistent finding may be related to differences in comorbidities that can affect physical well-being.
Consistent with previous studies, 65,66 lower functional status was associated with membership in the lower physical and social well-being as well as overall QOL classes. In our study, the mean KPS score for the Fig. 3 . a) Differences between the social well-being (SWB) latent classes in the percentages of patients who were homozygous for the common allele (GG) or heterozygous or homozygous for the rare allele (GC þ CC) for rs1143623 in interleukin 1 beta (IL1B). Values are plotted as unadjusted proportions with corresponding P-value. b) Differences between the total quality of life (QOL) latent classes in the percentages of patients who were homozygous for the common allele (AA) or heterozygous or homozygous for the rare allele (AC þ CC) for rs1881457 in interleukin 13 (IL13). Values are plotted as unadjusted proportions with corresponding P-value. c) Differences between the total quality of life (QOL) classes in the percentages of patients who were homozygous or heterozygous for the common allele (AA þ AG) or homozygous for the rare allele (GG) for rs4648068 in nuclear factor kappa beta 1 (NFKB1). Values are plotted as unadjusted proportions with corresponding P-value. patients in the lower physical well-being class indicates that they reported ''some'' signs or symptoms of disease that required effort to carry on normal activity. In addition, the difference in KPS scores between the two physical well-being classes represents not only a statistically significant but also a clinically meaningful difference in this score (i.e., Cohen's d ¼ 0.95). 67 Although the differences in KPS scores between the social well-being and total QOL classes were statistically significant, they were not clinically meaningful. These inconsistent findings may be explained by the fact that the overall KPS score for the entire sample was high (i.e., 93.223 [AE10.296]). An alternative explanation may be that even small decrements in functional status can have a differential impact on various domains, as well as overall QOL. 68 Consistent with previous reports, 6,8,69e71 receipt of adjuvant CTX was associated with membership in the lower QOL classes. The higher symptom burden associated with CTX may result in poorer physical and social well-being as well as overall QOL. For example, increased pain during intercourse from vaginal dryness as a side effect of CTX 71 may lead to decreased satisfaction with sex life and decreased support from partners contributing to poorer social well-being. 72 BMI remained significant in only one of the ordinal logistic regression analyses, namely for physical wellbeing. Consistent with previous reports, 73,74 compared to the higher class, patients in the changing physical well-being class had a higher BMI. Although the mean BMIs for both classes are in the ''overweight'' category, 75 this finding suggests that even small decreases in BMI may improve the physical well-being of women after breast cancer surgery.
Polymorphisms Associated With Latent Class Memberships
This study is the first to evaluate for associations between polymorphisms in cytokine genes and QOL outcomes in women after breast cancer surgery. Of note, across the three QOL outcomes, the genetic associations were completely different. For physical well-being, three genes (i.e., CXCL8, NFKB2, TNFSF ) were associated with membership in lower QOL classes. For CXCL8 rs4073, patients who were homozygous for the rare ''A'' allele had a decreased risk of being in the changing physical well-being class compared to the higher physical well-being class. According to SNPinfo, this SNP is located in the promoter region of the gene and may alter gene expression by changing transcriptional factor binding sites (TFBSs) for transcriptional factors involved in the transcription of DNA into RNA. CXCL8 belongs to a family of chemokines that are responsible for the elimination of pathogens through recruitment and activation of leukocytes during inflammation. 76 Carrying the rare ''A'' allele for CXCL8 rs4073 is associated with a variety of conditions including cancer susceptibility, 77e79 infection, 80 and chronic inflammation. 81e83 Consistent with our findings, in a previous study, 84 patients who were homozygous for the rare ''A'' allele in CXCL8 rs4073 had a lower risk of CTX toxicities. Perhaps, carriers of the rare ''A'' allele experience fewer symptoms or adverse effects from treatment that contribute to decrements in physical well-being.
For NFKB2 rs11574849, patients who were homozygous for the rare ''A'' allele had a decreased risk of being in the lower physical well-being class than in the changing class. NFKB2 encodes for one-half of the NFKB protein, which is a central transcriptional For each model, the first three principal components identified from the analysis of ancestry informative markers as well as self-reported race/ethnicity (i.e., white, black, Asian/Pacific Islander, Hispanic/mixed ethnic background/other) were retained in all models to adjust for potential confounding due to race or ethnicity (data not shown). Predictors evaluated in each model included genotype (IL13 rs1881457: AA vs. AC þ CC; NFKB1 rs4648068: AA þ AG vs. GG), age (in 10-year increments), KPS score (in 10-point increments), and whether the patient received chemotherapy during the first six months after surgery (i.e., adjuvant CTX). modulator of inflammation. 85 NFKB2 rs11574849 is located in the intron region of the gene and has no known function. Although no studies were identified that evaluated this SNP, it may be that this SNP is in LD with other functional variants of the same gene.
For TNFSF rs1800683, patients who were heterozygous or homozygous for the rare ''A'' allele had an increased risk of being in the lower physical wellbeing class compared to the changing physical well-being class. TNFSF rs1800683 is located in the coding region of the lymphotoxin alpha (LTA) gene and is part of the promoter region of TNFSF. According to SNPinfo, this SNP may affect TNFSF expression by altering TFBSs or disrupting messenger RNA splicing and affect LTA protein function. TNFSF and LTA are involved in a broad range of biologic functions including immune responses. 86 Consistent with the findings from this study, the rare ''A'' allele for TNFSF rs1800683 was associated with higher fatigue 87 and wake after sleep onset in adults living with HIV/AIDS, 88 and less evening energy in oncology patients and their family caregivers. 43 Only one SNP was associated with social well-being class membership. For IL1B rs1143623, patients who were heterozygous or homozygous for the rare ''C'' allele had an increased risk of being in the lower social well-being class. According to SNPinfo, IL1B rs1143623 is located in the promoter region of the gene and may alter gene expression by changing TFBSs. IL1B is involved in a number of cellular activities including cell proliferation, differentiation, and apoptosis, as well as being an important mediator of acute and chronic inflammatory responses. 89 The rare ''C'' allele in this SNP was associated with gout, 90 reduced drug efficacy in Type 2 diabetes patients, 91 cancer, 92,93 higher triglycerides and cholesterol, 94 and rheumatoid arthritis. 95 The relationship between this SNP and social well-being requires further exploration. However, the variety in the conditions associated with this SNP highlights the potential widespread involvement of this SNP in cellular activities.
Two SNPs were associated with overall QOL class membership. For IL13 rs1881457, patients who were heterozygous or homozygous for the rare ''C'' allele had an increased risk of being in the lower total QOL class. According to SNPinfo, IL13 rs1881457 is located in the promoter region of the gene and may alter gene expression by affecting TFBSs. Critical to immune responses to allergens, IL13 induces antibody synthesis. 96 In a study of patients with nonesmall-cell lung cancer undergoing CTX, 97 decreased survival and greater disease recurrence were reported in carriers of the rare ''C'' allele for IL13 rs1881457. Our finding is partially supported by a review of the literature 98 that highlights the association between poorer QOL scores and poorer survival in cancer patients.
For NFKB1 rs4648068, patients who were homozygous for the rare ''G'' allele had an increased risk of being in the lower total QOL class. NFKB1 rs4648068 is located in the intron region of NFKB1 and has no known function. In a limited number of studies, rs4648068 was associated with increased risk of ovarian 99 and gastric 100e102 cancer. This study is the first to identify an association between NFKB1 rs4648068 and outcomes other than cancer risk.
It should be noted that this study's findings and conclusions are preliminary and require replication. The generalizability of our findings is limited to breast cancer patients. Indeed, none of the cytokine gene associations identified in our previous study of QOL outcomes in oncology patients and their FCs were significant in the present study. 16, 17 Reasons for these differences may be related to differences in participant characteristics such as the inclusion of FCs in the sample and/or differences in the impact or timing of different cancer treatments on QOL outcomes. Finally, although our sample size was sufficient, larger samples may identify additional latent classes, as well as other phenotypic and genotypic associations.
Conclusions
Findings from this study confirm that women experience distinctly different physical well-being, social well-being, and total QOL outcomes during and after breast cancer surgery. Factors such as younger age, poorer functional status, higher BMI, and receipt of adjuvant CTX may place women at greater risk for poorer QOL. Although most of these factors were reported previously, they should be used by clinicians to identify high-risk patients before surgery. This type of risk profiling may allow for more tailored interventions to support these patients. Furthermore, understanding unique genomic markers would allow for earlier identification of cancer patients at higher risk for poorer QOL outcomes.
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This study was funded by grants from the National Cancer Institute (NCI, CA107091 and CA118658). Dr. Christine Miaskowski is an American Cancer Society Clinical Research Professor and is supported by a K05 award from the NCI (CA168960). Dr. Alexander was supported by a Research Career Development Award from the Oncology Nursing Foundation. This project was supported by NIH/NCRR UCSF-CTSI, grant number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. 0.184 T > C n/a n/a n/a n/a n/a n/a IL2 rs2069772 0.241 A > G 0.50 0.974 1.85 0.397 2.27 0.321 IL2 rs2069777 0.047 C > T n/a n/a n/a n/a n/a n/a IL2 rs2069763 0. 0.269 C > T n/a n/a n/a n/a n/a n/a IL4 rs2070874 0.245 C > T n/a n/a n/a n/a n/a n/a IL4 rs2227284 0.387 C > A n/a n/a n/a n/a n/a n/a IL4 rs2227282 0.390 C > G n/a n/a n/a n/a n/a n/a IL4 rs2243263 0.124 C > G 2.76 0.599 1.40 0.497 1.25 0.536 IL4 rs2243266 0.237 G > A n/a n/a n/a n/a n/a n/a IL4 rs2243267 0.237 G > C n/a n/a n/a n/a n/a n/a IL4 rs2243274 0.261 G > A n/a n/a n/a n/a n/a n/a IL4 0.134 C > G n/a n/a n/a n/a n/a n/a IL6 rs1800795 0. 0.061 T > C n/a n/a n/a n/a n/a n/a 0.024 C > T n/a n/a n/a n/a n/a n/a IL6 rs2069861 0.056 C rs17032779 0.011 T > C n/a n/a n/a n/a n/a n/a NFKB1 rs230510 0. 0.010 C > T n/a n/a n/a n/a n/a n/a NFKB1 rs4648018 0.018 G > C n/a n/a n/a n/a n/a n/a NFKB1 rs3774956 0.435 C > T 2.63 0.621 0.26 0.878 1.29 0.525 NFKB1 rs10489114 0.018 A > G n/a n/a n/a n/a n/a n/a NFKB1 rs4648068 0. Recessive model fits the data best. Otherwise, the additive model fits the data best.
